Glycosylation and the activation of proteinase-activated receptor 2 (PAR2) by human mast cell tryptase

被引:92
作者
Compton, SJ [1 ]
Renaux, B
Wijesuriya, SJ
Hollenberg, MD
机构
[1] Univ Calgary, Fac Med, Dept Pharmacol & Therapeut, Diabet & Endocrine Res Grp, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Fac Med, Dept Med, Calgary, AB T2N 4N1, Canada
关键词
tryptase; PAR2; glycosylation;
D O I
10.1038/sj.bjp.0704303
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Human mast cell tryptase appears to display considerable variation in activating proteinase-activated receptor 2 (PAR(2)). We found tryptase to be an inefficient activator of wild-type rat-PAR(2) (wt-rPAR(2)) and therefore decided to explore the factors that may influence tryptase activation of PAR(2). 2 Using a 20 mer peptide (P20) corresponding to the cleavage/activation sequence of wt-rPAR2, tryptase was as efficient as trypsin in releasing the receptor-activating sequence (SLIGRL...). However, in the presence of either human-PAR(2) or wt-r PAR(2) expressing cells, tryptase could only activate PAR(2) by releasing SLIGRL from the P20 peptide, suggesting that PAR(2) expressed on the cells was protected from tryptase activation. 3 Three approaches were employed to test the hypothesis that PAR, receptor glycosylation restricts tryptase activation. (a) pretreatment of wt-rPAR(2) expressing cells or human embryonic kidney cells (HEK293) with vibrio cholerae neuraminidase to remove oligosaccharide sialic acid, unmasked tryptase-mediated PAR(2) activation. (b) Inhibiting receptor glycosylation in HEK293 cells with tunicamycin enabled tryptase-mediated PAR(2) activation. (c) Wt-rPAR(2) devoid of the N-terminal glycosylation sequon (PAR(2)T25(-)), but not rPAR(2) devoid of the glycosylation sequon located on extracellular loop-2 (PAR(2)T224A), was selectively and substantially (> 30 fold) more sensitive to tryptase compared with the wt-rPAR(2). 4 Immunocytochemistry using antisera that specifically recognized the N-terminal precleavage sequence of PAR(2) demonstrated that tryptase released the precleavage domain from PAR(2)T25(-) but not from wt-rPAR(2). 5 Heparin : tryptase molar ratios of greater than 2: 1 abrogated tryptase activation of PAR(2)T25(-). 6 Our results indicate that glycosylation of PAR(2) and heparin-inhibition of PAR(2) activation by tryptase could provide novel mechanisms for regulating receptor activation by tryptase and possibly other proteases.
引用
收藏
页码:705 / 718
页数:14
相关论文
共 46 条
  • [41] TUNICAMYCIN INHIBITS THE EXPRESSION OF FUNCTIONAL THROMBIN RECEPTORS ON HUMAN T-LYMPHOBLASTOID CELLS
    TORDAI, A
    BRASS, LF
    GELFAND, EW
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 206 (03) : 857 - 862
  • [42] Vergnolle N, 1999, J IMMUNOL, V163, P5064
  • [43] Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw
    Vergnolle, N
    Hollenberg, MD
    Sharkey, KA
    Wallace, JL
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (05) : 1083 - 1090
  • [44] MOLECULAR-CLONING OF A FUNCTIONAL THROMBIN RECEPTOR REVEALS A NOVEL PROTEOLYTIC MECHANISM OF RECEPTOR ACTIVATION
    VU, TKH
    HUNG, DT
    WHEATON, VI
    COUGHLIN, SR
    [J]. CELL, 1991, 64 (06) : 1057 - 1068
  • [45] PRODUCTION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR HUMAN MAST-CELL TRYPTASE
    WALLS, AF
    BENNETT, AR
    MCBRIDE, HM
    GLENNIE, MJ
    HOLGATE, ST
    CHURCH, MK
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 1990, 20 (05) : 581 - 589
  • [46] Cloning and characterization of human protease-activated receptor 4
    Xu, WF
    Andersen, H
    Whitmore, TE
    Presnell, SR
    Yee, DP
    Ching, A
    Gilbert, T
    Davie, EW
    Foster, DC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) : 6642 - 6646